Medico Remedies Limited

NSE: MEDICO · Unclassified

₹17.99-2.49%06 Nov 2026

Ask the data

Instant answers about Medico Remedies Limited — computed from its filings, no language model

Market cap₹149 cr

Current price₹17.99

High / Low₹54 / ₹18

P/E10.8

P/B1.98

Book value₹9.1

ROE18.3%

ROCE22.2%

Debt / equity0.25

Dividend yield—

EPS (TTM)₹1.67

Face value₹2

Price & valuation

split & bonus adjusted · pick a metric and range

Annual performance

annual · ₹ crore · line = operating margin

	FY23	FY24	FY25	FY26
Revenue	140.4	144.9	150.9	206.4
EBITDA	9.6	12.9	15.0	17.0
Operating margin	6.8%	8.9%	9.9%	8.3%
Interest	0.8	0.8	1.2	1.8
Depreciation	2.7	2.9	3.0	3.1
Profit before tax	10.1	11.3	13.5	18.1
Tax	2.9	3.0	3.4	4.9
Net profit	7.2	8.3	10.1	13.1
EPS ₹	0.87	1.00	1.22	1.58
Operating cash flow	8.2	2.4	4.9	5.9
Capex	0.0	0.0	0.0	0.0
Dividend paid	0.0	0.0	0.0	0.0
Total assets	87.5	96.2	119.6	153.4
Equity	43.8	52.4	62.3	75.5

Quarterly performance

last 18 quarters · ₹ crore

showing latest 8 of 18 periods

	SEP '21†	JUN '22	SEP '22	DEC '22	MAR '23	JUN '23	SEP '23	DEC '23	MAR '24	JUN '24	SEP '24	DEC '24	MAR '25	JUN '25	SEP '25	DEC '25	MAR '26	JUN '26
Revenue	58.6	33.1	40.5	38.9	28.0	31.5	42.4	29.8	41.3	30.8	39.4	39.5	41.3	38.2	52.6	58.7	56.8	69.4
Operating profit	2.8	-0.2	3.1	3.4	3.2	2.5	3.1	2.7	4.7	2.8	2.4	3.1	6.7	2.8	2.7	4.3	7.2	3.3
Operating margin	4.7%	-0.5%	7.8%	8.7%	11.3%	7.8%	7.3%	9.2%	11.3%	9.1%	6.1%	7.9%	16.2%	7.4%	5.2%	7.4%	12.6%	4.8%
Other income	1.1	1.6	1.6	0.9	0.0	0.3	1.0	0.3	0.6	0.3	0.7	1.4	0.3	0.7	1.7	0.7	2.9	1.2
Interest	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.3	0.5	0.3	0.2	0.4	0.9	0.4
Depreciation	0.9	0.6	0.7	0.7	0.7	0.7	0.7	0.7	0.7	0.8	0.8	0.8	0.8	0.8	0.7	0.8	0.8	0.7
Profit before tax	2.6	0.7	3.9	3.3	2.3	1.9	3.1	2.1	4.2	2.2	2.1	3.5	5.7	2.4	3.5	3.8	8.3	3.3
Tax	0.8	0.3	1.0	1.1	0.5	0.6	0.7	0.6	1.1	0.6	0.6	0.9	1.4	0.6	0.9	1.0	2.5	0.8
Net profit	1.8	0.4	2.9	2.2	1.8	1.3	2.4	1.4	3.1	1.6	1.6	2.6	4.3	1.8	2.6	2.9	5.9	2.5
EPS ₹	4.38	0.22	1.73	1.36	0.21	0.16	0.29	0.17	0.37	0.19	0.19	0.32	0.52	0.22	0.31	0.70	0.71	0.30
Revenue YoY	—	—	-31.0%	—	—	-5.0%	4.7%	-23.4%	47.6%	-2.1%	-7.1%	32.7%	-0.0%	24.2%	33.8%	48.6%	37.6%	81.4%
Profit YoY	—	—	57.7%	—	—	266.7%	-15.3%	-35.6%	75.1%	19.7%	-36.2%	80.7%	40.0%	15.2%	65.8%	9.5%	35.0%	38.5%

Returns & margins

trailing-twelve-month, per quarter

showing latest 8 of 14 periods

	MAR '23	JUN '23	SEP '23	DEC '23	MAR '24	JUN '24	SEP '24	DEC '24	MAR '25	JUN '25	SEP '25	DEC '25	MAR '26	JUN '26
ROE	16.5%	18.7%	16.3%	14.6%	15.8%	16.3%	13.8%	15.9%	16.2%	16.6%	17.0%	17.3%	17.4%	18.3%
ROCE	20.2%	22.5%	21.0%	18.7%	20.1%	20.6%	17.2%	19.4%	19.1%	19.5%	20.8%	21.4%	21.1%	22.2%
Net margin	5.2%	5.9%	5.5%	5.3%	5.7%	5.9%	5.4%	5.9%	6.7%	6.5%	6.6%	6.1%	6.4%	5.8%
EBITDA margin	6.8%	8.8%	8.6%	8.7%	8.9%	9.2%	8.9%	8.6%	9.9%	9.5%	8.9%	8.7%	8.3%	7.4%
Debt / equity	0.22	0.22	0.14	0.14	0.15	0.15	0.21	0.21	0.24	0.24	0.18	0.18	0.25	0.25
Interest coverage	14.47	16.11	14.96	12.99	14.82	15.01	13.35	14.11	12.65	11.92	12.71	12.02	10.97	10.77
Asset turnover	1.61	1.59	1.37	1.29	1.51	1.50	1.43	1.52	1.26	1.32	1.25	1.39	1.35	1.55

Balance sheet

equity vs borrowings over time · ₹ crore

showing latest 6 of 8 periods

	SEP '22	MAR '23	SEP '23	MAR '24	SEP '24	MAR '25	SEP '25	MAR '26
Share capital	16.6	16.6	16.6	16.6	16.6	16.6	16.6	16.6
Other equity / reserves	23.2	27.2	31.0	35.8	38.9	45.7	50.3	58.9
Total equity	39.8	43.8	47.6	52.4	55.5	62.3	66.9	75.5
Borrowings	12.1	9.8	6.6	8.1	11.4	14.7	11.9	18.8
Current liabilities	53.5	41.5	53.1	42.8	42.7	57.0	70.4	77.6
Non-current liabilities	2.9	2.1	1.7	1.0	0.8	0.4	0.1	0.3
Total assets	96.2	87.5	102.3	96.2	99.0	119.6	137.4	153.4
Property, plant & equipment	21.3	20.3	20.9	20.3	20.9	20.5	20.3	20.1
Capital work-in-progress	0.0	1.5	0.0	1.1	—	1.1	0.5	2.6
Investments	1.1	0.0	0.0	1.6	1.6	1.6	1.7	1.9
Inventories	22.1	19.7	15.8	16.3	17.1	26.7	41.4	30.0
Receivables	42.8	36.1	56.0	49.6	51.4	57.2	57.4	82.0
Cash & equivalents	0.1	0.9	1.0	0.2	0.1	1.1	0.3	1.9

Cash flow

annual · ₹ crore · line = free cash flow

	FY23	FY24	FY25	FY26
Cash from operations	8.2	2.4	4.9	5.9
Cash from investing	-6.6	-2.7	-3.5	-4.5
Cash from financing	-1.8	-0.5	-0.5	-0.6
Capex	0.0	0.0	0.0	0.0
Free cash flow	8.2	2.4	4.9	5.9
Dividends paid	0.0	0.0	0.0	0.0

Where the assets sit

Mar '26 · ₹ crore

Fixed assets (PPE)

₹20.1 cr13%

CWIP

₹2.6 cr2%

Investments

₹1.9 cr1%

Inventories

₹30.0 cr20%

Receivables

₹82.0 cr53%

Cash & equivalents

₹1.9 cr1%

Other assets

₹14.9 cr10%

Peer comparison

largest in Unclassified · this company in bold

Company	Market cap ₹cr	Price	P/E	P/B	ROE
Avantel Limited	36,86,04,549	138.69	—	1059360.68	0.0%
Ducol Organics And Colours Limited	19,55,275	120.00	—	20089.13	0.0%
Jio Platforms Limited	12,57,181	1,406.40	—	3.57	—
SBI Funds Management Limited	1,01,750	499.55	—	—	—
Tamilnadu Telecommunication Limited	91,314	9.93	—	—	—
Manipal Health Enterprises Limited	76,294	646.70	—	—	—
INDO-MIM Limited	59,042	1,219.50	—	—	—
AvenuesAI Limited	45,138	129.25	153.6	9.51	6.2%
Dhoot Transmission Limited	32,761	1,601.60	—	8.11	—
3M India Limited	31,071	27,570.00	53.8	17.57	32.7%
Medico Remedies Limited	149	17.99	10.8	1.98	18.3%

StoxGud checklist: Neutral setup · 4/10

Price above 50-day average
Price above 200-day average
50-day average above 200-day (uptrend)
RSI in healthy 40–70 zone
Positive 1-year return
Return on equity above 15%
Debt to equity below 1
Revenue growing year on year
Net profit margin above 10%
P/E below industry median

A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.

Returns & technicals

1 month-19.6%

6 months-57.2%

1 year-62.6%

3Y CAGR-37.6%

5Y CAGR—

10Y CAGR—

50-day avg₹27.97

200-day avg₹39.39

RSI (14)14

FAQs

What is the share price of Medico Remedies Limited?

Medico Remedies Limited (MEDICO) closed at ₹17.99 on NSE on 06 Nov 2026.

What is the market cap of Medico Remedies Limited?

₹149 crore at the latest close.

What is the P/E ratio of Medico Remedies Limited?

10.8, on trailing-twelve-month earnings from its filings.

How fast is Medico Remedies Limited growing?

Medico Remedies Limited: revenue has compounded at 13.7% a year over three years; net profit at 21.9% a year. Latest-quarter revenue is up 81.4% year on year, profit up 38.5%.

How profitable is Medico Remedies Limited?

On a trailing-twelve-month basis return on equity is 18.3%, return on capital employed 22.2%, operating margin 7.4%, net margin 5.8%.

How much debt does Medico Remedies Limited have?

Medico Remedies Limited is lightly geared: debt to equity is 0.25 with borrowings of ₹19 cr against cash of ₹2 cr (balance sheet of 2026-03-31). Operating profit covers interest 10.8 times.

Financials parsed from Medico Remedies Limited's own XBRL filings to NSE (standalone), ₹ crore unless marked. Quarterly from SEP '21, annual from FY23, balance sheet from Sep '22. * = derived (full year or half year minus earlier quarters). † = the company's standalone results as published on BSE, used for quarters before JUN '22 (full years marked † are summed from them); cross-checked against the NSE filings where both exist. Information only, not investment advice.